Clinical trial NCT07534592 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-09-18 → 2026-08-28 3. primary completion date: 2026-09-18 → 2026-08-28 4. enrollment: 40 → 48 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06466187 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2029-05-01 → 2026-05-27 3. primary completion date: 2028-05-01 → 2026-05-27
Clinical trial NCT07646548: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT06843590 updates: 1. completion date: 2026-06-01 → 2026-11-01 2. primary completion date: 2026-06-01 → 2026-11-01 3. enrollment: 96 → 126 participants
Clinical trial NCT06052631: start date: 2026-06-28 → 2026-06-29.
Clinical trial NCT06433921 updates: 1. completion date: 2026-11-06 → 2027-02-26 2. primary completion date: 2026-10-30 → 2027-02-26
Clinical trial NCT06137144 updates: 1. completion date: 2029-04-30 → 2029-05-03 2. primary completion date: 2029-04-30 → 2029-05-03
Clinical trial NCT06369467 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-03-28 → 2027-08-31 3. primary completion date: 2028-03-28 → 2027-08-31 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06628362 updates: 1. primary completion date: 2026-06-01 → 2026-05-29 2. enrollment: 360 → 447 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06118086 updates: 1. completion date: 2027-06-01 → 2027-09-30 2. primary completion date: 2026-06-01 → 2027-09-30 3. enrollment: 100 → 125 participants